Svenska Cellulosa AB SCA Class A · OMXSTO:SCA_A

Svenska Cellulosa AB SCA Class A — SCA — Cheuvreux conference (May 2012)

22 slides from Svenska Cellulosa AB SCA Class A's conference presentation, May 22, 2012

  1. Slide 1: Cheuvreux conference

    Cheuvreux conference Mats Berencreutz, Executive Vice President

  2. Slide 2: SCA Group in 2011

    SCA Group in 2011  Net sales of SEK 106bn  44,000 employees and sales in more than 100 countries  World’s third-largest hygiene company  TEN and Tork are leading global brands for incontinence care and AFH tissue  Europe’s second-largest packaging company*  Europe’s largest private forest owne

  3. Slide 3: Leading market positions

    Leading market positions Globally and regionally Nordic region North America Incontinence products: 1 Europe AFH tissue: 3 Baby diapers: 1 Tissue: 1 Incontinence products: 3 AFH tissue: 1 Corrugated board: 2 Consumer tissue: 2 Solid-wood products: 2 Mexico Baby diapers: 3 Incontinence products: 1 In

  4. Slide 4: Strong global and regional brands

    Strong global and regional brands Two global billion EUR brands Eastern Europe Europe North America Asia Pacific Latin America 4 May 2012

  5. Slide 5: Major changes

    Major changes  Acquisition of Georgia-Pacific’s European tissue operations  Divestment of the Packaging business, excluding the two kraftliner mills  Established joint venture in Australia/New Zealand  Acquisition of Everbeauty an Asian hygiene products company  Increased shareholding in Vinda

  6. Slide 6: Acquisition of Georgia-Pacific's European tissue operations

    Acquisition of Georgia-Pacific’s European tissue operations  Creates a leading European tissue company  Strengthens SCA’s product offering and geographic presence  Sales: EUR 1.25bn  Purchase price: EUR 1.32bn  Annual synergies: EUR 125m  With full implementation of synergies, earnings per sha

  7. Slide 7: Georgia-Pacific acquisition: Substantial synergies

    Georgia-Pacific acquisition Substantial synergies  Increased supply chain efficiency  Optimization of logistics  More efficient sourcing  Improved SG&A and A&P efficiency  Annual synergies: EUR 125m  Improves Tissue EBIT margins by 2-2.5 percentage points  Full effect in 3 years after closing

  8. Slide 8: Georgia-Pacific acquisition: Enhances presence in tissue

    Georgia-Pacific acquisition Enhances SCA’s presence in Consumer and AFH tissue European Consumer tissue market 25% SCA SCA and GP 35% European AFH tissue market SCA and GP SCA 20% 30% 8 May 2012

  9. Slide 9: Georgia-Pacific acquisition: Increased share of branded sales

    Georgia-Pacific acquisition Increased share of branded consumer tissue sales SCA’s Consumer tissue sales SCA SCA and GP Retailers’ Branded brands Branded Retailers’ 40% 50% brands 9 May 2012

  10. Slide 10: Divestment of Packaging operations

    Divestment of Packaging operations  Divestment of Packaging operations to DS Smith  Excludes SCA’s two kraftliner mills in Sweden  Sales: SEK 24.4bn  Purchase price: EUR 1.7bn on a debt-free basis  Earnings per share declines by SEK 0.73* * Based on earnings for the period for 2011 10 May 2012

  11. Slide 11: SCA Group after completion of ongoing transactions

    SCA Group After completion of ongoing transactions  Net sales of SEK 92bn  37,000 employees and sales in more than 100 countries  World’s second-largest hygiene company  TEN and Tork are leading global brands for incontinence care and AFH tissue  Europe’s largest private forest owner  Europe’s

  12. Slide 12: Hygiene business is growing

    SCA Group Hygiene business is growing % of net sales ~20%* 54% 40% 46% 60% ~80%* Forest Products and Hygiene products Packaging (Personal Care and Tissue) * Provided that the Packaging divestment and the acquisition of Georgia-Pacific’s European tissue business are closed according to plan. 12 May 2

  13. Slide 13: SCA Group's strategic priorities

    SCA Group’s strategic priorities EFFICIENCY INNOVATION GROWTH 13 May 2012

  14. Slide 14: Efficiency

    Efficiency  Restructuring programme in baby diapers in Europe completed  Efficiency programme  Mainly related to Personal Care and Tissue  Annual cost saving: SEK 700m  Gradual impact in 2012-2013  Investments in upgrade of existing and new capacity 14 May 2012

  15. Slide 15: Innovation

    Innovation Strengthens market positions and profitability 15 May 2012

  16. Slide 16: Growth

    Growth  Organic growth of 4%*  High growth in emerging markets  Acquisition of Georgia-Pacific´s European tissue operations  Acquisition in Brazil  Pro Descart, No. 2 in incontinence care  Acquisition in Turkey  San Saglik 95%, No. 2 in incontinence care  Komili 50%, No. 4 in baby diapers an

  17. Slide 17: Acquisition of Everbeauty

    Acquisition of Everbeauty Leading Asian personal care company  Sales: SEK 1.6bn*  Sales split: baby diapers 60% and incontinence products 40%  Purchase price: SEK 1.9bn  Sales in China, Taiwan and Southeast Asia  Strong brands, market positions and distribution • Incontinence care products • No

  18. Slide 18: Growth potential for hygiene products

    Growth Growth potential for hygiene products  Global population growth  An aging population  Increased market penetration  Higher disposable income  Customers and consumers demand more comfort and sustainability 18 May 2012

  19. Slide 19: High potential in markets with low penetration

    Growth High potential in markets with low penetration Usage of hygiene products Units/capita/year Units/child/year Units/woman/year Kg/capita/year North America Western Europe Eastern Europe Latin America Asia 19 May 2012

  20. Slide 20: High growth in emerging markets

    Growth High growth in Emerging markets Q1 2012 Emerging markets sales growth: Personal Care: +23%* Tissue: +14%* % of Personal Care sales % of Tissue sales Emerging markets 18% Emerging markets 35% Mature markets Mature markets * Adjusted for exchange rate movements 20 May 2012

  21. Slide 21: Q&A

    Q&A 21 May 2012

  22. Slide 22: IR Contacts

    IR Contacts: Johan Karlsson, VP Investor Relations Jessica Ölvestad, Manager Investor Relations Tel: +46 8 788 51 30 Tel: +46 8 788 52 82 Email: ir@sca.com Website: www.sca.com

SCA — Cheuvreux conference (May 2012) on 6ix